ADIM
PHR icon

Alpha DNA Investment Management’s Phreesia PHR Stock Holding History

Alpha DNA Investment Management’s Portfolio PHR Stock Details PHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-130
Closed -$6K – 490
2021
Q1 		$6K Buy
+130
New +$8.19K 0.01% 339

Other funds holding PHR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Alpha DNA Investment Management's PHR Position: Q2 2021 in Review

Alpha DNA Investment Management sold out of Phreesia (PHR) in Q2 2021, closing a stake of 130 shares — an estimated $6K sold.

Alpha DNA Investment Management first reported a position in PHR in Q1 2021 and held it in 1 quarter. The position peaked at $6K in Q1 2021. 185 funds tracked by Wall St. Rank hold PHR as of Q2 2021.

  • Alpha DNA Investment Management reported no remaining Phreesia position as of Q2 2021 after selling out during the quarter.
  • Alpha DNA Investment Management sold 130 Phreesia shares in Q2 2021, an estimated $6K.
  • Alpha DNA Investment Management first reported a position in Phreesia in Q1 2021 and held it in 1 quarter.
  • Alpha DNA Investment Management's Phreesia position peaked at $6K in Q1 2021.
  • 185 funds tracked by Wall St. Rank held Phreesia as of Q2 2021.

Based on Alpha DNA Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.